Elucidating how molecules bind to HSA is fundamental for predicting drug incompatibilities. Through combinatorial screening, we identified a novel fluorescent dye (BD140) with turn-on fluorescence emission and specific binding at HSA drug site 2. We further combined it with dansylamide to develop a fluorescent dye cocktail for high-throughput mapping of the interaction between therapeutics at HSA drug-binding sites.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1021/co400060b | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!